Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 33, Issue 11, Pages 568-573Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2012.08.001
Keywords
-
Categories
Funding
- NIH [RO1 DA22576, RO1 DE18214, P20 DA26002]
Ask authors/readers for more resources
The current gap between basic science research and the development of new analgesics presents a serious challenge for the future of pain medicine. This challenge is particularly difficult in the search for better treatment for comorbid chronic pain conditions because: (i) animal 'pain' models do not simulate multidimensional clinical pain conditions; (ii) animal behavioral testing does not assess subjective pain experience; (iii) preclinical data provide little assurance regarding the direction of new analgesic development; and (iv) clinical trials routinely use over-sanitized study populations and fail to capture the multidisciplinary consequences of comorbid chronic pain. Therefore, a paradigm shift in translational pain research is necessary to transform the current strategy from focusing on molecular switches of nociception to studying pain as a system-based integral response that includes psychosocial comorbidities. Several key issues of translational pain research are discussed in this review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available